Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to polypharmacy status

A Peikert, P Goyal, M Vaduganathan, BL Claggett… - Heart Failure, 2023 - jacc.org
Background Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …

Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status

A Peikert, P Goyal, M Vaduganathan, BL Claggett… - JACC: Heart Failure, 2023 - Elsevier
Background Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …

Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status

A Peikert, P Goyal, M Vaduganathan… - JACC: Heart …, 2023 - research.rug.nl
Background: Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …

Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status

A Peikert, P Goyal, M Vaduganathan, BL Claggett… - 2023 - pubmed.ncbi.nlm.nih.gov
Background Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …

Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status

A Peikert, P Goyal, M Vaduganathan… - JACC: Heart …, 2023 - scholars.northwestern.edu
Background: Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …

Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status

A Peikert, P Goyal, M Vaduganathan… - JACC: Heart …, 2023 - experts.umn.edu
Background: Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …

Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to polypharmacy status

A Peikert, P Goyal, M Vaduganathan… - JACC: Heart …, 2023 - eprints.gla.ac.uk
Background: Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …